Picture of Haemonetics logo

HAE — Haemonetics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Haemonetics Corp reports results for the quarter ended in March - Earnings Summary

* Haemonetics Corp  HAE.N  reported quarterly adjusted
earnings of
90 cents​​ per share for the quarter ended in March, higher than
the same quarter last year, when the company reported EPS of 77
cents.  The mean expectation of seven analysts for the quarter
was for earnings of 89 cents per share. Wall Street expected
results to range from 88 cents to 92 cents per share.
    * Revenue rose 12.8% to $343.29 million from a year ago;
analysts
expected $329.11 million. 
    * Haemonetics Corp's reported EPS for the quarter was 40
cents​.
    * The company reported quarterly net income of $20.37
million.
    * Haemonetics Corp shares had risen by 9.3% this quarter and
gained 9.1% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 1.9%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"

Wall Street's median 12-month price target for Haemonetics Corp
is $105.00 
This summary was machine generated from LSEG data May 9 at 11:52
a.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      0.89           0.90           Beat
 Dec. 31 2023      0.94           1.04           Beat
 Sep. 30 2023      0.89           0.99           Beat
 Jun. 30 2023      0.73           1.05           Beat

Recent news on Haemonetics

See all news